Vaccinations Related Content

A new study has revealed that COVID-19 antibodies fade after only a month, which could be a devastating blow in the global race to find a vaccine.

Russia is the first country to announce the approval of a COVID-19 vaccine, without completing clinical trials.

Professor Martin Michaelis and Dr Mark Wass, School of Biosciences at University of Kent, explain the long and infamous history of human infection trials.

Scientists from the University of Oxford, joint with AstraZeneca, are hopeful that their vaccine, to protect against Covid-19, could be available as early as September.

The Immunisation For All Ages group discusses the importance of protecting vaccine budgets and immunisation infrastructure, even amidst COVID-19.

President von der Leyen, Council President Charles Michel and Prime Minister of Japan Shinzō Abe, discussed the global response to the COVID-19 pandemic.

Here we summarise a discussion with experts on the EU response to COVID-19 and the role of Horizon Europe in this pandemic.

Researchers have found that people who use social media for news are more likely to experience vaccine misinformation.

The Government has today pledged £20 million to develop a new coronavirus vaccine following concerns over the ongoing outbreak in China.

Here, we focus on some of the key issues facing the pharmaceutical industry throughout Europe.

International Development Secretary Alok Sharma has pledged new UK aid support to help vaccinate more than 400 million children a year against polio.

Parents of primary school starters urged to check immunisation records after Public Health England (PHE) warns that 1 in 7 five-year-olds may not be fully immunised against MMR.

PM Johnson wants to improve vaccination uptake after more than 230 cases of measles were reported in the UK due to the anti-vaccination movement.

A report published by the International Longevity Centre UK (ILC-UK), supported by Sanofi Pasteur, suggests that efforts to increase vaccination coverage need to present immunisation as a positive and healthy lifestyle choice.

Technology could play a major role in overcoming some of the barriers to the uptake of adult vaccinations argues a new report, “Data, bots and drones”, published by the International Longevity Centre UK (ILC).

Q fever is an emerging problem in low and middle-income countries (LMIC) and, therefore, there is a need for improved vaccines, in the view of Head of Disease Control at Moredun Research Institute.

WHO released a Global Influenza Strategy for 2019-2030 aimed at protecting people in all countries from the threat of influenza.

More children are being vaccinated against measles in Europe; progress has been uneven between and within countries, leaving increasing clusters of susceptible individuals unprotected.

Government has published 5-year national action plan and a 20-year vision for how the UK will contribute to containing and controlling antimicrobial resistance.

The UK government will give £10 million of funding to the Coalition for Epidemic Preparedness Innovations (CEPI) to help develop vaccines.